LEDS vs NVDA

The deterministic health profile is critically weak, headlined by a Piotroski F-Score of 3/9 and a total absence of a Graham Number due to negative earnings. While the company shows an anomalous surge in revenue growth (103.7%), this has failed to translate into profitability, as evidenced by a devastating ROE of -72.62% and an operating margin of -40.52%. Liquidity is a primary concern with a Quick Ratio of 0.44, suggesting a high risk of insolvency. Combined with a 0/100 technical trend and a consistent multi-year history of losses, the stock exhibits classic characteristics of a value trap.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.